Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Jinhai International Group Holdings Limited ( (HK:2225) ).
Jinhai Medical Technology Limited has announced a change in its principal place of business in Hong Kong, effective from November 19, 2025. The relocation to Chinachem Century Tower in Wanchai signifies a strategic move that could enhance its operational efficiency and market positioning within the region.
The most recent analyst rating on (HK:2225) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Jinhai International Group Holdings Limited stock, see the HK:2225 Stock Forecast page.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited is a company incorporated in the Cayman Islands, operating within the medical technology industry. It focuses on providing medical products and services, with a market presence in Hong Kong.
Average Trading Volume: 11,440,951
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.98B
Find detailed analytics on 2225 stock on TipRanks’ Stock Analysis page.